首页> 外文期刊>BMC Cancer >A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer
【24h】

A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer

机译:胃癌淋巴结转移术前预测的基因组临床病理学脊髓图

获取原文
           

摘要

Preoperative evaluation of lymph node (LN) state is of pivotal significance for informing therapeutic decisions in gastric cancer (GC) patients. However, there are no non-invasive methods that can be used to preoperatively identify such status. We aimed at developing a genomic biosignature based model to predict the possibility of LN metastasis in GC patients. We used the RNA profile retrieving strategy and performed RNA expression profiling in a large GC cohort (GSE62254, n?=?300) from Gene Expression Ominus (GEO). In the exploratory stage, 300 GC patients from GSE62254 were involved and the differentially expressed RNAs (DERs) for LN-status were determined using the R software. GC samples in GSE62254 were randomly allocated into a learning set (n?=?210) and a verification set (n?=?90). By using the Least absolute shrinkage and selection operator (LASSO) regression approach, a set of 23-RNA signatures were established and the signature based nomogram was subsequently built for distinguishing LN condition. The diagnostic efficiency, as well as the clinical performance of this model were assessed using the decision curve analysis (DCA). Metascape was used for bioinformatic analysis of the DERs. Based on the genomic signature, we established a nomogram that robustly distinguished LN status in the learning (AUC?=?0.916, 95% CI 0.833–0.999) and verification sets (AUC?=?0.775, 95% CI 0.647–0.903). DCA demonstrated the clinical value of this nomogram. Functional enrichment analysis of the DERs was performed using bioinformatics methods which revealed that these DERs were involved in several lymphangiogenesis-correlated cascades. In this study, we present a genomic signature based nomogram that integrates the 23-RNA biosignature based scores and Lauren classification. This model can be utilized to estimate the probability of LN metastasis with good performance in GC. The functional analysis of the DERs reveals the prospective biogenesis of LN metastasis in GC.
机译:淋巴结(LN)状态的术前评价对于胃癌(GC)患者提供治疗决策的关键意义。但是,没有可用于术前识别这种状态的非侵入性方法。我们旨在开发基于基于基于基于基因生物关键的模型,以预测GC患者LN转移的可能性。我们使用RNA分布检索策略,并在大GC队列(GSE62254,N-3 3)中进行RNA表达分析来自基因表达ominus(Geo)。在探索性阶段,涉及来自GSE62254的300gc患者,并且使用R软件确定LN状态的差异表达的RNA(DER)。 GSE62254中的GC样本被随机分配到学习集中(n?=?210)和验证集(n?=Δ90)。通过使用最小的绝对收缩和选择操作员(套索)回归方法,建立了一组23 RNA签名,随后构建了基于签名的墨迹图以区分LN条件。使用判定曲线分析(DCA)评估诊断效率,以及该模型的临床性能。 ForeScape用于DERS的生物信息分析。基于基于基于基因组签名,我们建立了一个粗暴地图,在学习(AUC?= 0.916,95%CI 0.833-0.999)和验证组(AUC?= 0.775,95%CI 0.647-0.903)中,建立了强大的LN状态DCA展示了该墨顶图的临床价值。使用生物信息学方法进行DER的功能性富集分析,所述生物信息学方法表明这些DERS参与了几种淋巴管发生相关的级联。在这项研究中,我们介绍了基于基于基于基于基于基于基于基于基于基于的基于ROM图,其集成了基于23 RNA生物关键的分数和Lauren分类。该模型可用于估计LN转移在GC中具有良好性能的可能性。 DERs的功能分析显示了GC中LN转移的前瞻性生物发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号